Open original FDA record ↗Recall record
- FDA identifier
- Z-0049-2018
- Company in FDA record
- Edap Technomed Inc.
- FDA record creation date
- Oct 26, 2017
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The US FDA has requested the optional energy treatment settings, "medium" and "low" (Software Protocols 02-Medium and 03-Low) be removed from all Ablatherm Integrated Imagining devices in the U.S. until supporting clinical data can be submitted and evaluated by FDA.
Source facts
- Action
- The firm, EDAP TMS, company contacted all affected customers by phone during the week of August 14, 2017 and followed up with an " URGENT FIELD SAFETY NOTICE" letter dated 8/22/2017 delivered by email on 08/29/2016. The letter described the product, problem and actions to be taken. The customers were instructed as follows: do not use the "medium" or "low" energy treatment power settings in the meantime.The devices will be serviced at the consignee to remove Protocols "02-medium" and "03-low". If you have any questions regarding this notification, or experience any issues with your device, please contact EDAP TMS Customer Care Center at (512) 852-9685 or via email at service@edap-usa.com at any time, 24 hours a day, 7 days a week.
- Initiated
- 2017-08-14
- Root cause
- Other
- Terminated
- 2020-08-04
- Distribution
- US Distribution to states of: NY, FL CA, NC, TX and NJ.
- Recall number
- Z-0049-2018
- Recall status
- Terminated
- CDRH record ID
- 158643
- FDA record created
- 2017-10-26
- Recall event number
- 78092